No. HT942526MRPSRA · Defense Health Agency Contracting Activity - DHACA
DoW Melanoma Research Program Survivorship Research Award
- Award range
- Not specified
- Expected awards
- ~2
- Application deadline
- Oct 14, 2026
- Posted
- May 21, 2026
- Last verified
- Today
At a glance
AI summaryThe FY26 Melanoma Research Program Survivorship Research Award funds innovative research to improve the health and well-being of melanoma survivors, their families, and care partners. Clinical trials are allowed, but studies focused only on animal models or on survival without quality of life, health, or function are not responsive. Eligible applicants include U.S. Department of War organizations and foreign or domestic, for-profit or nonprofit, public or private organizations; the principal investigator must be an independent investigator at or above assistant professor level or equivalent. The program expects to fund about two awards at roughly $1.02 million total cost cap each, with no cost-sharing requirement and a maximum project period of 3 years. Applications must include at least one melanoma consumer collaborator, and the program says research involving military or Veteran populations, data, or resources is highly encouraged.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity. Distinctive Features: · The application must include at least one melanoma consumer collaborator , defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research. · Clinical trials are allowed.
Who can apply
- Unrestricted
Program history
USASpending.govAssistance listing 12.420 · Military Medical Research and Development
Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 374 | $934,195 | $559,998 – $1,477,811 |
| FY 2025 | 967 | $796,174 | $416,995 – $1,480,602 |
| FY 2024 | 1,097 | — | — |
| FY 2023 | 1,115 | — | — |
| FY 2022 | 1,186 | — | — |
| FY 2021 | 1,023 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
- UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
- UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025
Source: USASpending.gov · refreshed Aug 25, 2026